Author： Gottschalk Uwe
Publisher： Future Science
ISSN： 2048-9145
Source： Pharmaceutical Bioprocessing, Vol.1, Iss.1, 2013-04, pp. : 7-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Obesity and Its Impact on Drug Therapy: Are We Ready for This Change?
Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. :
Dronedarone: is it time to turn it down?
Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. :
Time to reconsider the risks of HRT?
Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. :
Eltroxin: formulation change cause of ADR increase?
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :